Tag Archives: NIH

Experimental Ebola Vaccine Seems to Be Safe in Test

An experimental vaccine to prevent Ebola virus disease has been found to be well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial, researchers report. The trials were conducted at US National Institutes of Health‚Äôs clinical centre in Bethesda, Maryland. The candidate vaccine is co-developed by the NIH’s National Institute ...

Read More »

ChAd3 Experimental Ebola Vaccine Safe Though in Trial Stage, say US Researchers

An experimental vaccine, ChAd3, to prevent Ebola virus disease has been found to be well-tolerated and produced immune system responses in all 20 healthy adults who received it in a Phase 1 clinical trial, US researchers¬†said. Mzapp is another vaccine under trials. The trials were conducted at US National Institutes of Health’s clinical centre in Bethesda, Maryland after they were ...

Read More »